| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 623989 | Null | 0.0102962192514439 | 0.52569124 |
| NSC 626878 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride | 0.0102962192514439 | 0.43392446 |
| NSC 627581 | Null | 0.0102962192514439 | 0.53891684 |
| NSC 628297 | Null | 0.0102962192514439 | 0.25876085 |
| NSC 634037 | 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazine | 0.0102962192514439 | 0.49246511 |
| NSC 639976 | Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride | 0.0102962192514439 | 0.57584177 |
| NSC 641389 | Null | 0.0102962192514439 | 0.5859818 |
| NSC 644916 | ANTINEOPLASTIC-644916 | 0.0102962192514439 | 0.50054466 |
| NSC 647751 | Null | 0.0102962192514439 | 0.56821546 |
| NSC 651922 | Null | 0.0102962192514439 | 0.45349802 |